Merck & Co Inc
NYSE: MRK
$96.31
-$2.05 (-2.1%)
Closing Price on November 15, 2024
MRK Articles
Merck & Co. (NYSE: MRK) posted earnings that look pretty good on the surface. The problem is that the surface is about the only thing that looked appealing for the drug giant today. Merck...
Published:
Last Updated:
These are not all of the upgrades or positive analyst calls seen this morning but these are some of the top calls seen this Friday morning: Aventine Renewable (NYSE: AVR) Raised to Buy from Neutral...
Published:
According to Reuters, Robert Steel was named the new CEO of Wachovia (WB) and the bank said it would have a quarter loss of $2.6 to $2.8 billion. Reuters writes that the Blue Chip Economic Indicators...
Published:
We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic site. The study showed that a combination of fish oil and red rice yeast in...
Published:
According to Reuters, Microsoft (MSFT) is willing to start buy-out talks with Yahoo! (YHOO) if the portal company will replace its board. Reuters writes that the CEO of JP Morgan (JPM) said the SEC...
Published:
These are ten of the analyst calls with upgrades and downgrades we are focusing on this Monday morning in pre-market trading: Acme Packet (NASDAQ: APKT) cut to Underweight at JPMorgan; cut to Neutral...
Published:
We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and other companies involved in various aspects of health care and medicine. ...
Published:
It used to be that DEFENSIVE STOCKS were the way to go during periods of uncertainty and during times of market sell-offs. But now that isn’t even working out. After we looked at our first line...
Published:
Today’s 52-week low list was full of some of the usual suspects, and you can count airlines as the top group of 52-week lows after that breather in oil prices did not hold. There were also many...
Published:
Last Updated:
According to Reuters, Microsoft’s (MSFT) Steve Ballmber said his company will not bid for Yahoo! (YHOO). Reuters writes that HP’s (HPQ) operating margin rose to 10% in the last quarter. Reuters...
Published:
Shares of Amgen Inc. (NASDAQ: AMGN) are seeing a small gain in after-hours trading. The troubled biotech giant announced that findings from its head-to-head, double-blind trial comparing the...
Published:
Last Updated:
Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its corporate structure, increasing focus on emerging markets such as China,...
Published:
Big Pharma continues to throw ballast out of the balloon in the hopes of staying aloft. The latest victim of declining fortunes in the industry is Merck (MRK), which seems to have had every drug...
Published:
According to Reuters, UBS (UBS) will cut 5,500 jobs. The company is also selling $15 billion in subprime mortgage paper to Blackrock. Reuters writes that Bernanke says that high foreclosure rates are...
Published:
There are lots of names moving in biotech and related fields today, and below are some of the top movers: Anika Therapeutics Inc. (NASDAQ: ANIK) moving up after reporting solid first quarter earnings...
Published: